Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29188480
Publication Date : //

A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells.


Tumor cells release extracellular vesicles (EVs) into the tumor microenvironment that may facilitate malignant progression and metastasis. Breast carcinoma EVs express high levels of the thrombospondin-1 and signal regulatory protein-α receptor CD47, which is the target of several experimental therapeutics currently in clinical trials. We analyzed changes in gene expression and function in human umbilical vein endothelial cells (HUVEC) induced by treatment with EVs derived from breast carcinoma cells and the effects of the function-blocking CD47 antibody B6H12 on the resulting intercellular communication. CD47 EVs exhibited greater uptake by HUVEC compared to CD47 EVs, but the CD47 antibody did not inhibit their uptake. Global and targeted analyses of transcripts demonstrated that treatment of HUVEC with EVs derived from MDA-MB-231 breast carcinomas cells altered pathways associated with tumor necrosis factor-α signaling, angiogenesis, lymphangiogenesis, endothelial-mesenchymal transition, and extracellular matrix. EVs from triple-negative MDA-MB-231 cells were more active than EVs from less metastatic breast carcinoma cell lines. Treatment with MDA-MB-231 EVs down-regulated VEGFR2 mRNA expression and tyrosine phosphorylation while enhancing phosphorylation of the tyrosine phosphatase SHP2. VEGFR2 expression and phosphorylation in HUVEC was further inhibited by the CD47 antibody. Consistent with the observed changes in endothelial-mesenchymal transition genes and SHP2, treatment with MDA-MB-231-derived EVs decreased Zeb1 protein levels in HUVEC, whereas the CD47 antibody increased Zeb1 levels. The induction of E-selectin and other known targets of tumor necrosis factor-α signaling by EVs was also enhanced by the CD47 antibody, and E-selectin was the most up-regulated transcript following CD47 antibody treatment alone. These studies reveal several mechanisms by which therapeutics targeting CD47 could modulate tumor growth by altering the cross talk between cancer-derived EVs and nonmalignant cells in the tumor stroma.

Authors : Kaur Sukhbir , Elkahloun Abdel G , Singh Satya P , Arakelyan Anush , Roberts David D ,

Related products :

Catalog number Product name Quantity
26-210 LAX1 is a single-pass type III membrane protein. It negatively regulates TCR (T-cell antigen receptor)-mediated signaling in T-cells and BCR (B-cell antigen receptor)-mediated signaling in B-cells. 0.05 mg
31-244 TAL-1 modulates the angiogenic response of endothelial cells by stimulating cell morphogenesis and by influencing their behavior in migration. 0.05 mg
30-595 FCRL1 may function as an activating coreceptor in B cells and it may function in B cells activation and differentiation. 0.1 mg
orb84823 TNF alpha protein Tumor necrosis factor alpha (TNF alpha) is produced by neutrophils, activated lymphocytes, macrophages, NK cells, LAK cells, astrocytes endothelial cells, smooth muscle cells and som 20
HEC23 Human Cord Blood CD34+ Cells Derived Endothelial Cells, 500,000+ Cells in T25 Flask.
31-236 POU5F1 is a POU transcription factor expressed by early embryo cells and germ cells. It determines paracrine growth factor signaling from stem cells to the trophectoderm 0.1 mg
SCH-MCA1752 MOUSE ANTI PIG ENDOTHELIAL CELLS, Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS, Target Species Pig, Host Mouse, Format S_N, Isotypes IgE, Applications C, Clone MIL11 2 ml
MCA1752 MOUSE ANTI PIG ENDOTHELIAL CELLS, Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS, Target Species Pig, Host Mouse, Format S_N, Isotypes IgE, Applications C, Clone MIL11 2 ml
orb84802 TNF alpha protein Tumor necrosis factor alpha (TNF alpha), also called cachectin, is produced by neutrophils, activated lymphocytes, macrophages, NK cells, LAK cells, astrocytes endothelial cells, smo 50
30-077 ERRs, which are coexpressed with ERs in prostatic cells, could regulate cell growth and modulate ER-mediated pathways via interference on ERalpha transcription in prostatic cells. Not only PNRC2 but a 0.05 mg
27-388 ERRs, which are coexpressed with ERs in prostatic cells, could regulate cell growth and modulate ER-mediated pathways via interference on ERalpha transcription in prostatic cells. Not only PNRC2 but a 0.1 mg
4108-2108 RAT ANTI HUMAN ENDOTHELIAL CELLS (FULLY DIFFERENTIATED), Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS , Target Species Human, Host Rat, Format Purified, Isotypes IgG2a, Applic 0.1 mg
SCH-4108-2108 RAT ANTI HUMAN ENDOTHELIAL CELLS (FULLY DIFFERENTIATED), Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS , Target Species Human, Host Rat, Format Purified, Isotypes IgG2a, Applic 0.1 mg
4108-2004 MOUSE ANTI HUMAN ENDOTHELIAL CELLS, Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS, Target Species Human, Host Mouse, Format Purified, Isotypes IgG2a, Applications C, P*, Clone 0.5 ml
SCH-4109-0004 MOUSE ANTI HUMAN ENDOTHELIAL CELLS (VEIN ASSOCIATED ANTIGEN), Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS , Target Species Human, Host Mouse, Format S_N, Isotypes IgG2a, Appl 0.5 ml
4109-0004 MOUSE ANTI HUMAN ENDOTHELIAL CELLS (VEIN ASSOCIATED ANTIGEN), Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS , Target Species Human, Host Mouse, Format S_N, Isotypes IgG2a, Appl 0.5 ml
SCH-4108-2004 MOUSE ANTI HUMAN ENDOTHELIAL CELLS, Product Type Monoclonal Antibody, Specificity ENDOTHELIAL CELLS, Target Species Human, Host Mouse, Format Purified, Isotypes IgG2a, Applications C, P*, Clone 0.5 ml
HEC16 Human Large Intestine Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC23 Human Cord Blood CD34+ Cells Derived Endothelial Cells 1.0flask
cAP-0024 Human Cord Blood CD34+ Cells Derived Endothelial Cells 1.00 flask
HEC17 Human Internal Mammary Artery Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC03 Human Dermal Lymphatic Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC09 Human Retinal Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC15 Human Small Intestine Endothelial Cells, 500,000+ Cells in T25 Flask.
HEC13 Human Prostate Microvascular Endothelial Cells, 500,000+ Cells in T25 Flask.


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur